Skip to main content
. 2024 Apr 8;3(2):e115. doi: 10.1002/cai2.115

Figure 3.

Figure 3

Monoclonal antibodies such as trastuzumab, infliximab, pembrolizumab, etc. help to kill cancer cells, marking the cancer cells so that the immune system can recognize the cells and destroy them [54], adopted with permission.